Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ Global Market (CRME).